We are live on
!
Find out more
FFGM
Founders Fund Growth Management Portfolio holdings
AUM
$7.04M
1-Year Est. Return
82.06%
This Fund
S&P 500
This Quarter
Est. Return
-17.63%
1 Year Est. Return
-82.06%
3 Year Est. Return
-48.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
–
Cap. Flow
+$234M
Cap. Flow
% of AUM
131.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Affirm
AFRM
|
+$214M |
| 2 |
Oscar Health
OSCR
|
+$10.7M |
| 3 |
AbCellera Biologics
ABCL
|
+$6.18M |
| 4 |
Opendoor
OPEN
|
+$2.39M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 91.93% |
| 2 | Healthcare | 7.04% |
| 3 | Real Estate | 1.03% |
Similar funds
MC
IVSFI
HM
NA
FFVM
FFVM
ICM
HFG
Founders Fund Growth Management's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Founders Fund Growth Management, which disclosed 4 positions worth $177M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Affirm: 1,622,338 shares worth $163M.
By sector, the portfolio is most concentrated in Financials at 92% of assets, followed by Healthcare and Real Estate.
- Founders Fund Growth Management's largest Q4 2021 buy was Affirm: 1,622,338 shares worth $163M.
- Founders Fund Growth Management's ten largest holdings make up 100% of its $177M portfolio in Q4 2021.
- Founders Fund Growth Management disclosed 4 positions in Q4 2021, its first 13F filing on record.
Based on Founders Fund Growth Management's 13F filing for Q4 2021, filed 14 Feb 2022.